0001683168-22-006851.txt : 20221012
0001683168-22-006851.hdr.sgml : 20221012
20221012170340
ACCESSION NUMBER: 0001683168-22-006851
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221003
FILED AS OF DATE: 20221012
DATE AS OF CHANGE: 20221012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White Chad Norman
CENTRAL INDEX KEY: 0001949607
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33216
FILM NUMBER: 221307354
MAIL ADDRESS:
STREET 1: 645 MOLLY LANE, SUITE 150
CITY: WOODSTOCK
STATE: GA
ZIP: 30189
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sonoma Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001367083
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680423298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 645 MOLLY LANE, SUITE 150
CITY: WOODSTOCK
STATE: GA
ZIP: 30189
BUSINESS PHONE: 800-759-9305
MAIL ADDRESS:
STREET 1: 645 MOLLY LANE, SUITE 150
CITY: WOODSTOCK
STATE: GA
ZIP: 30189
FORMER COMPANY:
FORMER CONFORMED NAME: Oculus Innovative Sciences, Inc.
DATE OF NAME CHANGE: 20060622
3
1
ownership.xml
X0206
3
2022-10-03
0
0001367083
Sonoma Pharmaceuticals, Inc.
SNOA
0001949607
White Chad Norman
C/O SONOMA PHARMACEUTICALS, INC.
645 MOLLY LANE, SUITE 150
WOODSTOCK
GA
30189
0
1
0
0
Interim CFO
Stock Option (right to buy)
2.21
2032-10-03
Common Stock
5000
D
The Issuer granted the options as an initial grant upon Mr. White's appointment as interim Chief Financial Officer of the Issuer. The options vest in three equal tranches annually on the grant date anniversary, beginning on October 3, 2023 and becoming fully vested on October 3, 2025, or upon change of control of the Issuer.
/s/ Chad N. White
2022-10-12